CODX has been granted a new patent
Jun 26, 2024, 10:38 PM
-17.78%
What does CODX do
Co-Diagnostics, Inc., based in Salt Lake City, Utah, specializes in developing molecular diagnostics for detecting infectious diseases, cancer screening, and agricultural uses, and went public in 2017. The company designs and distributes reagents and equipment, including a developing portable PCR device, for simplified molecular testing in various settings.
CODX filed a patent for "methods and systems for analyzing nucleic acids using increased ifret with multiple acceptor fluorophores" on Fri, December 23, 2022. The patent was officially published on Thu, September 7, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.